Vir Biotechnology, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.

Symbol
VIR on Nasdaq
Location
San Francisco, CA
Fiscal year end
31 December
Latest financial report
23 Feb 2026

Latest SEC snapshot (2026-02-17) highlights Return On Equity -45.7%, Return On Assets -36.5%, and Operating Margin -699.2%.

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

22.3/100

Weak Confidence medium

Return On Equity

-46%

Metric score 0.0/100

Return On Assets

-36%

Metric score 0.0/100

Financial Health

Current Ratio
5.54x

Strengths

NetIncomeLoss YoY

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-46%

YoY: +20%

Industry median: -48% (n=217)

View history

Return On Assets

-36%

YoY: +16%

Industry median: -46% (n=216)

View history

Operating Margin

-699%

YoY: -12%

Industry median: -332% (n=95)

View history

Current Ratio

5.54x

YoY: -36%

Industry median: 3.73x (n=218)

View history

Revenues YoY

-7.6%

YoY:

Industry median: 16% (n=41)

View history

NetIncomeLoss YoY

16%

YoY:

Industry median: -9.9% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -46% +20%
Return On Assets -36% +16%
Operating Margin -699% -12%

Financial Health

Metric Latest value YoY change
Current Ratio 5.54x -36%

Growth

Metric Latest value YoY change
Revenues YoY -7.6%
NetIncomeLoss YoY 16%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 139,517,278 +0.92%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%